Baxter International | BAX - Stammkapital

Aktienkurs
18.16
Täglich Wechseln
-0.25 -1.36%
Monatlich
6.07%
Jährlich
-39.91%
Q2 Prognose
17.77




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Fresenius EUR 563.24M 0 2025-09
Globus Medical USD 135.06M 449K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Quest Diagnostics USD 111M 1000K 2026-03
Smith & Nephew USD 875.96M 1.61M 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Terumo JPY 1.48B 0 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12